Citius Pharmaceuticals, INC. (CTXR) — 10-K Filings
All 10-K filings from Citius Pharmaceuticals, INC.. Browse 1 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (1)
-
Citius Pharma Goes Commercial with LYMPHIR Launch, Faces Going Concern Doubt
— Dec 23, 2025 Risk: high
Citius Pharmaceuticals, Inc. (CTXR) launched LYMPHIR in December 2025 through its majority-owned subsidiary, Citius Oncology, marking its transition to a commer
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX